Skip to main content
Premium Trial:

Request an Annual Quote

Agreement Gives Agilent Access to BIA Separations' Bio-monolithic Technology

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has reached an agreement with BIA Separations that gives it access to BIA Separations’ Convective Interaction Media bio-monolithic technology.
 
Agilent said it will use the technology to develop HPLC columns with strong and weak ion-exchange phases and a protein A phase.
 
Access to the technology will enable Agilent to provide "enabling solutions" for the separation of virus particles, plasmid DNA, antibodies and other large biomolecules, said Helen Stimson, Agilent's VP and GM of global columns and supplies solutions.
 
"This technology, when applied at the analytical scale, will improve bio-drug characterization in development and allow QA/QC and process control labs to better monitor and characterize the production of biologics,” she added.
 
The partnership will also allow BIA Separations "to focus its marketing and sales efforts on preparative and process scale bio-chromatography applications,” said Ales Strancar, managing director of Klagenfurt, Austria-based BIA.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.